SCHEMBL5906875

SCHEMBL5906875

COC(=O)C(Cc1ccccc1)Nc1cc(-c2ccccc2NC(=O)OC(C)(C)C)ncn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK5 Q9Y337 1/20 0.46
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C8 P10632 1/20 0.45
NPR3 P17342 1/20 0.45
ACE P12821 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.40
CTSS P25774 2/20 0.40
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
CTSK P43235 1/20 0.40
APP P05067 1/20 0.39
BRD9 Q9H8M2 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5906879 1.00 KLK5 (0.46) KLK5CYP2C9CYP2C19CYP3A4CYP2C8
SCHEMBL5906929 0.85 NPR3 (0.51) KLK5CYP2C9CYP2C19CYP3A4CYP2C8
SCHEMBL5906925 0.85 NPR3 (0.51) KLK5CYP2C9CYP2C19CYP3A4CYP2C8
SCHEMBL5906626 0.77 CYP2C19 (0.41) CYP2C9CYP2C19ALDH1A1MEN1KMT2A
SCHEMBL5906627 0.77 CYP2C19 (0.41) CYP2C9CYP2C19ALDH1A1MEN1KMT2A
SCHEMBL5906642 0.76 ITGB1 (0.52) CYP2C9CYP2C19CYP3A4ALDH1A1MEN1
SCHEMBL5906645 0.76 ITGB1 (0.52) CYP2C9CYP2C19CYP3A4ALDH1A1MEN1
SCHEMBL5906839 0.76 ITGB1 (0.52) CYP2C9CYP2C19CYP3A4ALDH1A1MEN1
SCHEMBL5906837 0.76 TACR3 (0.47) CYP2C19CYP3A4ALDH1A1MEN1KMT2A
SCHEMBL5906861 0.76 ELANE (0.48) CYP2C19CYP3A4ALDH1A1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060089371-A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist BAYER HEALTHCARE AG (DE) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089371-A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist BPHL, HRH4, HRH2 KLK5 524/4885CYP2C9 818/4885CYP2C19 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.